Pharmacology

Action Mechanism of Action Reference
INHIBITOR Tubulin inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Breast Neoplasms 2 D001943 ClinicalTrials
Hemangiosarcoma 2 D006394 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1629760-29-7
ChEMBL CHEMBL4298101
FDA SRS VM4G5D1A60